These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 23376323)

  • 21. Similarity of the phenotypic patterns associated with BRAF and KRAS mutations in colorectal neoplasia.
    Yuen ST; Davies H; Chan TL; Ho JW; Bignell GR; Cox C; Stephens P; Edkins S; Tsui WW; Chan AS; Futreal PA; Stratton MR; Wooster R; Leung SY
    Cancer Res; 2002 Nov; 62(22):6451-5. PubMed ID: 12438234
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A comprehensive study of nondysplastic and dysplastic serrated polyps of the vermiform appendix.
    Yantiss RK; Panczykowski A; Misdraji J; Hahn HP; Odze RD; Rennert H; Chen YT
    Am J Surg Pathol; 2007 Nov; 31(11):1742-53. PubMed ID: 18059232
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Left-sided early-onset vs late-onset colorectal carcinoma: histologic, clinical, and molecular differences.
    Pilozzi E; Maresca C; Duranti E; Giustiniani MC; Catalanotto C; Lucarelli M; Cogoni C; Ferri M; Ruco L; Zardo G
    Am J Clin Pathol; 2015 Mar; 143(3):374-84. PubMed ID: 25696795
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serrated lesions of the appendix in serrated polyposis patients.
    Bettington M; Brown IS; Rosty C
    Pathology; 2016 Jan; 48(1):30-4. PubMed ID: 27020206
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Down-regulation of p21 (CDKN1A/CIP1) is inversely associated with microsatellite instability and CpG island methylator phenotype (CIMP) in colorectal cancer.
    Ogino S; Kawasaki T; Kirkner GJ; Ogawa A; Dorfman I; Loda M; Fuchs CS
    J Pathol; 2006 Oct; 210(2):147-54. PubMed ID: 16850502
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinicopathological and molecular features of colorectal serrated neoplasias with different mucosal crypt patterns.
    Yano Y; Konishi K; Yamochi T; Katagiri A; Nozawa H; Suzuki H; Toyota M; Kubota Y; Muramoto T; Kobayashi Y; Tojo M; Konda K; Makino R; Kaneko K; Yoshikawa N; Ota H; Imawari M
    Am J Gastroenterol; 2011 Jul; 106(7):1351-8. PubMed ID: 21427714
    [TBL] [Abstract][Full Text] [Related]  

  • 27. KRAS mutations and CDKN2A promoter methylation show an interactive adverse effect on survival and predict recurrence of rectal cancer.
    Kohonen-Corish MR; Tseung J; Chan C; Currey N; Dent OF; Clarke S; Bokey L; Chapuis PH
    Int J Cancer; 2014 Jun; 134(12):2820-8. PubMed ID: 24259266
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Involvement of the serrated neoplasia pathway in inflammatory bowel disease-related colorectal oncogenesis.
    Bossard C; Denis MG; Bézieau S; Bach-Ngohou K; Bourreille A; Laboisse CL; Mosnier JF
    Oncol Rep; 2007 Nov; 18(5):1093-7. PubMed ID: 17914558
    [TBL] [Abstract][Full Text] [Related]  

  • 29. TGFBR2 mutation is correlated with CpG island methylator phenotype in microsatellite instability-high colorectal cancer.
    Ogino S; Kawasaki T; Ogawa A; Kirkner GJ; Loda M; Fuchs CS
    Hum Pathol; 2007 Apr; 38(4):614-20. PubMed ID: 17270239
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serrated lesions of the appendix frequently harbor KRAS mutations and not BRAF mutations indicating a distinctly different serrated neoplastic pathway in the appendix.
    Pai RK; Hartman DJ; Gonzalo DH; Lai KK; Downs-Kelly E; Goldblum JR; Liu X; Patil DT; Bennett AE; Plesec TP; Kuan SF; Nikiforova MN; Shadrach B; Pai RK
    Hum Pathol; 2014 Feb; 45(2):227-35. PubMed ID: 24439221
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic and epigenetic classifications define clinical phenotypes and determine patient outcomes in colorectal cancer.
    Sanchez JA; Krumroy L; Plummer S; Aung P; Merkulova A; Skacel M; DeJulius KL; Manilich E; Church JM; Casey G; Kalady MF
    Br J Surg; 2009 Oct; 96(10):1196-204. PubMed ID: 19787768
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Colorectal advanced neoplasms occur through dual carcinogenesis pathways in individuals with coexisting serrated polyps.
    Yamada A; Minamiguchi S; Sakai Y; Horimatsu T; Muto M; Chiba T; Boland CR; Goel A
    PLoS One; 2014; 9(5):e98059. PubMed ID: 24849572
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CpG island methylation is frequently present in tubulovillous and villous adenomas and correlates with size, site, and villous component.
    Kakar S; Deng G; Cun L; Sahai V; Kim YS
    Hum Pathol; 2008 Jan; 39(1):30-6. PubMed ID: 17950780
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Investigating the potential role of genetic and epigenetic variation of DNA methyltransferase genes in hyperplastic polyposis syndrome.
    Drini M; Wong NC; Scott HS; Craig JM; Dobrovic A; Hewitt CA; Dow C; Young JP; Jenkins MA; Saffery R; Macrae FA
    PLoS One; 2011 Feb; 6(2):e16831. PubMed ID: 21347319
    [TBL] [Abstract][Full Text] [Related]  

  • 35. p53 mutation is common in microsatellite stable, BRAF mutant colorectal cancers.
    Bond CE; Umapathy A; Ramsnes I; Greco SA; Zhen Zhao Z; Mallitt KA; Buttenshaw RL; Montgomery GW; Leggett BA; Whitehall VL
    Int J Cancer; 2012 Apr; 130(7):1567-76. PubMed ID: 21557216
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Deletion mutation of BRAF in a serrated adenoma from a patient with familial adenomatous polyposis.
    Lee EJ; Park CK; Kim JW; Chang DK; Kim KM
    APMIS; 2007 Aug; 115(8):982-6. PubMed ID: 17696956
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Mutations of KRAS and BRAF in Chinese patients with colorectal carcinoma: analyses of 966 cases].
    Gao J; Sun ZW; Li YY; Shen L
    Zhonghua Bing Li Xue Za Zhi; 2012 Sep; 41(9):579-83. PubMed ID: 23157823
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hyperplastic polyps of the colon and rectum - reclassification, BRAF and KRAS status in index polyps and subsequent colorectal carcinoma.
    Janjua HG; Høgdall E; Linnemann D
    APMIS; 2015 Apr; 123(4):298-304. PubMed ID: 25708741
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mutation pattern of KRAS and BRAF oncogenes in colorectal cancer patients.
    Rako I; Jakic-Razumovic J; Katalinic D; Sertic J; Plestina S
    Neoplasma; 2012; 59(4):376-83. PubMed ID: 22489692
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Both BRAF and KRAS mutations are rare in colorectal carcinomas from patients with hereditary nonpolyposis colorectal cancer.
    Miyaki M; Iijima T; Yamaguchi T; Kadofuku T; Funata N; Mori T
    Cancer Lett; 2004 Jul; 211(1):105-9. PubMed ID: 15194222
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.